The first evidence of constitutive NF-κB activity in thyroid cancer cell lines was reported in 1997: in that study, the authors showed that NF-κB function was an absolute requirement for the neoplastic phenotype of thyroid cancer cells [15]. Here, NFKB1 is linked to thyroid cancer.